← Open Payments lookup

MORGAN DONNELLAN DENSFORD: Open Payments

NPI 1427724210 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$830 in 43 payments from 13 companies in 2025. Trend: 2023 $516 · 2024 $1,125 · 2025 $830

Food & beverage: $830
CompanyPaymentsAmount
ABBVIE INC.13$180
GENZYME CORPORATION5$108
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$95
Regeneron Healthcare Solutions, Inc.4$82
QOL Medical, LLC4$77
Takeda Pharmaceuticals U.S.A., Inc.2$52
Ardelyx, Inc.3$50
Pharmacosmos Therapeutics Inc.1$48
Celltrion USA Inc.2$39
Digestive Care, Inc.1$38

Products named: DUPIXENT, XIFAXAN, Sucraid, SKYRIZI, RINVOQ, EOHILIA, IBSRELA, MONOFERRIC.

Industry payments across MD — which companies pay providers there.